(NBIX) Neurocrine Biosciences - Performance -21.4% in 12m
Compare NBIX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
13.13%
#32 in Group
Rel. Strength
26.77%
#5595 in Universe
Total Return 12m
-21.37%
#66 in Group
Total Return 5y
18.73%
#39 in Group
P/E 33.6
78th Percentile in Group
P/E Forward 22.8
67th Percentile in Group
PEG 0.27
65th Percentile in Group
FCF Yield 5.22%
90th Percentile in Group
12m Total Return: NBIX (-21.4%) vs XBI (-11%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: NBIX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NBIX
| Total Return (including Dividends) | NBIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -5.39% | -5.85% | -3.01% |
| 3 Months | -21.43% | -11.95% | -3.15% |
| 12 Months | -21.37% | -11.00% | 10.19% |
| 5 Years | 18.73% | 0.65% | 129.24% |
| Trend Score (consistency of price movement) | NBIX | XBI | S&P 500 |
| 1 Month | -0.40% | -59.8% | -5.5% |
| 3 Months | -80.9% | -70.5% | -58.4% |
| 12 Months | -45.1% | -6.9% | 84.1% |
| 5 Years | 54.0% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #74 | 0.49% | -2.46% |
| 3 Month | #84 | -10.8% | -18.9% |
| 12 Month | #67 | -11.7% | -28.6% |
| 5 Years | #39 | 18.0% | -48.2% |
FAQs
Does NBIX Neurocrine Biosciences outperforms the market?
No,
over the last 12 months NBIX made -21.37%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months NBIX made -21.43%, while XBI made -11.95%.
Over the last 3 months NBIX made -21.43%, while XBI made -11.95%.
Performance Comparison NBIX vs Indeces and Sectors
NBIX vs. Indices NBIX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.64% | -2.38% | -4.82% | -31.6% |
| US NASDAQ 100 | QQQ | -3.66% | -1.33% | -4.05% | -30.0% |
| US Dow Jones Industrial 30 | DIA | -4.84% | -3.25% | -5.74% | -30.9% |
| German DAX 40 | DAX | -3.34% | -2.01% | -21.6% | -43.1% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.35% | -5.62% | 10.4% | -30.5% |
| Hongkong Hang Seng | HSI | -6.61% | -8.16% | 4.40% | -38.7% |
| India NIFTY 50 | INDA | -5.67% | -13.3% | 5.53% | -22.1% |
| Brasil Bovespa | EWZ | -4.75% | -13.7% | 3.18% | -9.63% |
NBIX vs. Sectors NBIX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.10% | -1.58% | -12.9% | -40.6% |
| Consumer Discretionary | XLY | -5.40% | -1.56% | -8.18% | -35.4% |
| Consumer Staples | XLP | -7.43% | -3.55% | -5.66% | -32.4% |
| Energy | XLE | -5.73% | -13.4% | -10.4% | -22.2% |
| Financial | XLF | -5.12% | -2.69% | -17.0% | -43.6% |
| Health Care | XLV | -5.06% | -2.23% | -0.12% | -23.1% |
| Industrial | XLI | -4.95% | -4.70% | -4.11% | -29.9% |
| Materials | XLB | -5.74% | -5.90% | 3.29% | -17.4% |
| Real Estate | XLRE | -6.68% | -2.70% | -1.70% | -34.7% |
| Technology | XLK | -3.51% | -1.38% | 0.30% | -23.4% |
| Utilities | XLU | -7.93% | -6.21% | -3.94% | -46.6% |
| Aerospace & Defense | XAR | -4.04% | -6.67% | -8.74% | -42.3% |
| Biotech | XBI | -0.08% | 0.46% | 12.9% | -10.4% |
| Homebuilder | XHB | -5.14% | -5.54% | 14.6% | -13.7% |
| Retail | XRT | -6.94% | -4.89% | -0.74% | -16.6% |